BONEH — BBS-Bioactive Bone Substitutes Oyj Share News
0.000.00%
Last trade - 00:00Brief: Bbs-Bioactive Bone Substitutes Rights Issue Subscribed To About 71.1%
Brief: BBS-Bioactive Bone Substitutes Says The Notified Body Has Approved Co’s Quality System
Brief: Bioactive Bone Substitutes Oyj Informed By Notified Body That Final Approval Of Quality System Is Expected Within Approximately One Month
Brief: BBS-Bioactive Bone Substitutes Appoints Juliusz Rakowski As New CEO
Brief: BBS Expects Decision On Approving CE Marking Application For ARTEBONE Paste In Q2 2024
Brief: BBS-Bioactive Bone Substitutes Resolves On Share Issue Without Consideration To Company
Brief: Bbs-Bioactive Bone Substitutes Gets Request For Conversion Of Convertible Notes
Brief: BBS H1 Loss Narrows To EUR 1.6 Mln
Brief: BBS' Rights Issue Raises Gross Proceeds Of EUR 1.84 Mln
Brief: BBS-Bioactive Bone Substitutes Says 57% Of Warrants Used For The Subscription Of Shares Raises EUR 162,000 In Gross Proceeds
Brief: BBS Arranges Rights Offering Of About Maximum EUR 2.9 Mln
Brief: BBS Receives Positive Decision On Product Classification
Brief: BBS-Bioactive Bone Substitutes Says Periodic Audit of Co's Pharmaceutical Factory Permit Successful
Brief: BBS-Bioactive Bone Substitutes H2 Financial Loss At EUR 1.42 Mln
Brief: BBS-Bioactive Bone Substitutes Says Last Day Of Trading In Shares Of BBS On Nasdaq First North Growth Market Sweden Shall Be March 3, 2023
Brief: BBS-Bioactive Bone Substitutes Applies For Delisting Of Secondary Listing On First North Sweden
Brief: BBS Sees Delay In CE Marking Approval Schedule Of Artebone Paste
Brief: BBS-Bioactive Bone Substitutes Resolves On Share Issue
Brief: BBSNames Jari Kortesluoma New CFO